ImmPort Study ID	PubMed	Study Title	PI	Biosample ID	Experiment ID	Cohort	Repository Accession	Type	Subtype	Biosample Name	Biosample Description	Species	Strain	Cancer Type	Tissue	Cell Type	Cell Line	Treatment
GSE103713	28864476	Expression changes in YUMM1.7 melanoma with/without PD-L2 overexpression under BRAFi treatment in NSG mice [Y1.7.FPKM.batch4]		SRX3176870	GSE103713	Y1.7-NSG-Ctrl-DMSO	GSM2779596	Melanoma	Cutaneous Melanoma (SKCM)	Y1.7-NSG-Ctrl-DMSO-1	YUMM1.7 melanoma tumor in NSG mice, vehicle treated, 1st tumor	Mus musculus	Y1.7-NSG-Ctrl-DMSO-1	Melanoma	YUMM1.7 melanoma	None	None	None
GSE103713	28864476	Expression changes in YUMM1.7 melanoma with/without PD-L2 overexpression under BRAFi treatment in NSG mice [Y1.7.FPKM.batch4]		SRX3176870	GSE103713	Y1.7-NSG-Ctrl-DMSO	GSM2779597	Melanoma	Cutaneous Melanoma (SKCM)	Y1.7-NSG-Ctrl-DMSO-2	YUMM1.7 melanoma tumor in NSG mice, vehicle treated, 2nd tumor	Mus musculus	Y1.7-NSG-Ctrl-DMSO-2	Melanoma	YUMM1.7 melanoma	None	None	None
GSE103713	28864476	Expression changes in YUMM1.7 melanoma with/without PD-L2 overexpression under BRAFi treatment in NSG mice [Y1.7.FPKM.batch4]		SRX3176870	GSE103713	Y1.7-NSG-Ctrl-DMSO	GSM2779598	Melanoma	Cutaneous Melanoma (SKCM)	Y1.7-NSG-Ctrl-DMSO-3	YUMM1.7 melanoma tumor in NSG mice, vehicle treated, 3rd tumor	Mus musculus	Y1.7-NSG-Ctrl-DMSO-3	Melanoma	YUMM1.7 melanoma	None	None	None
GSE103713	28864476	Expression changes in YUMM1.7 melanoma with/without PD-L2 overexpression under BRAFi treatment in NSG mice [Y1.7.FPKM.batch4]		SRX3176870	GSE103713	Y1.7-NSG-Pdl2OE-DMSO	GSM2779599	Melanoma	Cutaneous Melanoma (SKCM)	Y1.7-NSG-Pdl2OE-DMSO-1	YUMM1.7 melanoma tumor with PD-L2 overexpression in NSG mice, vehicle treated, 1st tumor	Mus musculus	Y1.7-NSG-Pdl2OE-DMSO-1	Melanoma	YUMM1.7 melanoma	None	None	None
GSE103713	28864476	Expression changes in YUMM1.7 melanoma with/without PD-L2 overexpression under BRAFi treatment in NSG mice [Y1.7.FPKM.batch4]		SRX3176870	GSE103713	Y1.7-NSG-Pdl2OE-DMSO	GSM2779600	Melanoma	Cutaneous Melanoma (SKCM)	Y1.7-NSG-Pdl2OE-DMSO-2	YUMM1.7 melanoma tumor with PD-L2 overexpression in NSG mice, vehicle treated, 2nd tumor	Mus musculus	Y1.7-NSG-Pdl2OE-DMSO-2	Melanoma	YUMM1.7 melanoma	None	None	None
GSE103713	28864476	Expression changes in YUMM1.7 melanoma with/without PD-L2 overexpression under BRAFi treatment in NSG mice [Y1.7.FPKM.batch4]		SRX3176870	GSE103713	Y1.7-NSG-Pdl2OE-DMSO	GSM2779601	Melanoma	Cutaneous Melanoma (SKCM)	Y1.7-NSG-Pdl2OE-DMSO-3	YUMM1.7 melanoma tumor with PD-L2 overexpression in NSG mice, vehicle treated, 3rd tumor	Mus musculus	Y1.7-NSG-Pdl2OE-DMSO-3	Melanoma	YUMM1.7 melanoma	None	None	None
GSE103713	28864476	Expression changes in YUMM1.7 melanoma with/without PD-L2 overexpression under BRAFi treatment in NSG mice [Y1.7.FPKM.batch4]		SRX3176870	GSE103713	Y1.7-NSG-Ctrl-BRAFi	GSM2779602	Melanoma	Cutaneous Melanoma (SKCM)	Y1.7-NSG-Ctrl-BRAFi-1	YUMM1.7 melanoma tumor in NSG mice, BRAFi treated, 1st tumor	Mus musculus	Y1.7-NSG-Ctrl-BRAFi-1	Melanoma	YUMM1.7 melanoma	None	None	None
GSE103713	28864476	Expression changes in YUMM1.7 melanoma with/without PD-L2 overexpression under BRAFi treatment in NSG mice [Y1.7.FPKM.batch4]		SRX3176870	GSE103713	Y1.7-NSG-Ctrl-BRAFi	GSM2779603	Melanoma	Cutaneous Melanoma (SKCM)	Y1.7-NSG-Ctrl-BRAFi-2	YUMM1.7 melanoma tumor in NSG mice, BRAFi treated, 2nd tumor	Mus musculus	Y1.7-NSG-Ctrl-BRAFi-2	Melanoma	YUMM1.7 melanoma	None	None	None
GSE103713	28864476	Expression changes in YUMM1.7 melanoma with/without PD-L2 overexpression under BRAFi treatment in NSG mice [Y1.7.FPKM.batch4]		SRX3176870	GSE103713	Y1.7-NSG-Ctrl-BRAFi	GSM2779604	Melanoma	Cutaneous Melanoma (SKCM)	Y1.7-NSG-Ctrl-BRAFi-3	YUMM1.7 melanoma tumor in NSG mice, BRAFi treated, 3rd tumor	Mus musculus	Y1.7-NSG-Ctrl-BRAFi-3	Melanoma	YUMM1.7 melanoma	None	None	None
GSE103713	28864476	Expression changes in YUMM1.7 melanoma with/without PD-L2 overexpression under BRAFi treatment in NSG mice [Y1.7.FPKM.batch4]		SRX3176870	GSE103713	Y1.7-NSG-Pdl2OE-BRAFi	GSM2779605	Melanoma	Cutaneous Melanoma (SKCM)	Y1.7-NSG-Pdl2OE-BRAFi-1	YUMM1.7 melanoma tumor with PD-L2 overexpression in NSG mice, BRAFi treated, 1st tumor	Mus musculus	Y1.7-NSG-Pdl2OE-BRAFi-1	Melanoma	YUMM1.7 melanoma	None	None	None
GSE103713	28864476	Expression changes in YUMM1.7 melanoma with/without PD-L2 overexpression under BRAFi treatment in NSG mice [Y1.7.FPKM.batch4]		SRX3176870	GSE103713	Y1.7-NSG-Pdl2OE-BRAFi	GSM2779606	Melanoma	Cutaneous Melanoma (SKCM)	Y1.7-NSG-Pdl2OE-BRAFi-2	YUMM1.7 melanoma tumor with PD-L2 overexpression in NSG mice, BRAFi treated, 2nd tumor	Mus musculus	Y1.7-NSG-Pdl2OE-BRAFi-2	Melanoma	YUMM1.7 melanoma	None	None	None
GSE103713	28864476	Expression changes in YUMM1.7 melanoma with/without PD-L2 overexpression under BRAFi treatment in NSG mice [Y1.7.FPKM.batch4]		SRX3176870	GSE103713	Y1.7-NSG-Pdl2OE-BRAFi	GSM2779607	Melanoma	Cutaneous Melanoma (SKCM)	Y1.7-NSG-Pdl2OE-BRAFi-3	YUMM1.7 melanoma tumor with PD-L2 overexpression in NSG mice, BRAFi treated, 3rd tumor	Mus musculus	Y1.7-NSG-Pdl2OE-BRAFi-3	Melanoma	YUMM1.7 melanoma	None	None	None
